Drug Profile


Alternative Names: CP 68722; CP 72467 02; CP 72467 2

Latest Information Update: 29 Mar 2000

Price : $50

At a glance

  • Originator Pfizer
  • Developer Nonindustrial source; Pfizer
  • Class Antihyperglycaemics; Antihyperlipidaemics; Small molecules; Thiazolidinediones
  • Mechanism of Action Peroxisome proliferator-activated receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Type 2 diabetes mellitus

Most Recent Events

  • 29 Mar 2000 No-Development-Reported for Type-2 diabetes mellitus in United Kingdom (Unknown route)
  • 08 Nov 1999 Discontinued-I for Type-2 diabetes mellitus in USA (Unknown route)
  • 16 Sep 1997 Preclinical development for Type-2 diabetes mellitus in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top